Caroline J. Fuery
Profile
Caroline J.
Fuery worked as a Director of Product Development at SpeeDx Pty Ltd.
from 2009 to 2014 and as a Research Manager at Johnson & Johnson Research Pty Ltd.
She received undergraduate and doctorate degrees from The University of Western Australia.
Former positions of Caroline J. Fuery
| Companies | Position | End |
|---|---|---|
| Johnson & Johnson Research Pty Ltd. | Chief Tech/Sci/R&D Officer | - |
SpeeDx Pty Ltd.
 SpeeDx Pty Ltd. BiotechnologyHealth Technology SpeeDx Pty Ltd. is a medical diagnostic company focused on the research, development and commercialization of molecular diagnostic detection technologies. It offers various technologies, including MNAzymes, which are multi-component nucleic acid enzymes composed of DNA to be adapted for sensitive and specific multiplexed detection of various target analytes, as well as catalytically modify substrates producing signals to indicate the presence of target; DNAzymes, which are deoxyribozymes or DNA enzymes to catalyze a repertoire of chemical reactions and are used in the sensor/nanotechnology arena, as well as used for human and animal health; and EzyAmp, an isothermal signal amplification cascade that utilizes restriction enzymes. The company was founded by Elisa E. Mokany and Alison V. Todd in 2009 and is headquartered in Eveleigh, Australia. | Corporate Officer/Principal | - |
Training of Caroline J. Fuery
| The University of Western Australia | Doctorate Degree |
Experiences
Positions held
Linked companies
| Private companies | 2 |
|---|---|
SpeeDx Pty Ltd.
SpeeDx Pty Ltd. BiotechnologyHealth Technology SpeeDx Pty Ltd. is a medical diagnostic company focused on the research, development and commercialization of molecular diagnostic detection technologies. It offers various technologies, including MNAzymes, which are multi-component nucleic acid enzymes composed of DNA to be adapted for sensitive and specific multiplexed detection of various target analytes, as well as catalytically modify substrates producing signals to indicate the presence of target; DNAzymes, which are deoxyribozymes or DNA enzymes to catalyze a repertoire of chemical reactions and are used in the sensor/nanotechnology arena, as well as used for human and animal health; and EzyAmp, an isothermal signal amplification cascade that utilizes restriction enzymes. The company was founded by Elisa E. Mokany and Alison V. Todd in 2009 and is headquartered in Eveleigh, Australia. | Health Technology |
| Johnson & Johnson Research Pty Ltd. |
- Stock Market
- Insiders
- Caroline J. Fuery
